CD20 immunotherapynon-Hodgkin’s lymphomaDiffuse large B-cell lymphoma (DLBCL)DLBCL
… this axis restored macrophage phagocytosis and synergized with CD20 immunotherapy to enhance its antitumor efficacy.Conclusion Our study defines …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,821–2,880 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
alternative treatment options1ambulatory oxygen therapy1amyloid-clearing therapies1anaesthetics1analgesic strategies1androgen receptor inhibitors1aneurysm embolization1angioplasty and stenting1angiotensin II receptor blocker1anteroseptal line ablation1anthracycline-based therapy1anti- H.pylori treatment1anti-CD19 CAR-T therapy1anti-CD20 therapies1anti-CGRP therapies1anti-CTLA4 therapy1anti-HER2 therapies1anti-HER2 therapy1anti-IL5R therapy1anti-PD therapy1anti-PD-(L)1 therapy1anti-PD-1 therapies1anti-PD-1/PD-L1 therapies1anti-TB therapy1anti-TNF treatment1anti-TNF-α therapy1anti-TNFα treatment1anti-aTNF therapy1anti-amyloid immunotherapy1anti-amyloid monoclonal antibody therapies1anti-cancer interventions1anti-cancer treatments1anti-eosinophilic biologic therapy1anti-fibrinolytic treatment1anti-fungal induction therapy1anti-hypertensives1anti-infective therapy1anti-infective treatment1anti-inflammation1anti-inflammatory analgesia1anti-inflammatory diet1anti-inflammatory strategies1anti-inflammatory-based management1anti-interleukin-1 therapy1anti-metabolite therapy1anti-metastatic therapies1anti-osteoporotic medication1anti-programmed cell death ligand-1(PD-L1) therapy1anti-programmed cell death protein 1 (PD-1) therapy1anti-programmed cell death protein 1 ICB1anti-programmed cell death protein 1 immunotherapy1anti-programmed cell death protein-1 (PD-1) therapy1anti-programmed cell death-ligand 1 immunotherapy1anti-programmed death-ligand 1 therapy1anti-pyretics1anti-reflux therapy1anti-rejection medication1anti-rejection medications1anti-respiratory syncytial virus (RSV) antibody prophylaxis1anti-rheumatic therapy1
Articles mentioning treatments
7,227 articles · page 322 of 603antiviral therapyValacicloviraciclovirHerpes zoster ophthalmicuspostherpetic neuralgiaHZOGlaxoSmithKlinezosterVaricella zoster virusShingrix+1 more
…ity of vision-threatening complications are moderated by prompt antiviral therapy. Valaciclovir has numerous advantages over aciclovir, including…
anticoagulationUniversity Hospital BirminghamUniversity Hospital of WalesFontanAdult Congenital Heart Disease
…on pathway from paediatric to adult care. Additionally, data on anticoagulation use and complications were collected to inform future research …
anti-thrombotic therapyNSTEMIfondaparinuxTWH
…Following reports of prescription errors in anti-thrombotic therapy in NSTEMI patients within Tunbridge Wells Hospital’s (TWH) Emer…
device therapyBBlockerheart failureHFrEFSGL2 InhibitorsNICE
…ad no related documentation. 9.6% passed away before discussing device therapy.Conclusion The data illustrate a notable difference in prescrib…
guideline directed treatmentfurosemideHull University Teaching Hospitals NHS TrustHeart failureHFHUTH NHS trust
…ts hospitalised with HF is associated with greater adherence to guideline directed treatment, and better outcomes. However, the number and need of patients …
hormone replacement therapymyocardial infarctioncardiovascular diseaseNICEOestrogenACSEuropean Society of CardiologymenopauseAmerican Heart AssociationACSOutcome+3 more
…ity of life. Post menopausal symptoms are commonly managed with hormone replacement therapy (HRT) to provide relief and improvement in quality of life. How…
catheter ablationthyroid dysfunctionAADsIron deficiencyVentricular tachycardia (VT)ischaemic cardiomyopathy
…lly managed with a combination of anti-arrhythmic drugs (AADs), catheter ablation, and optimisation of anti-tachycardia therapies. However, speci…
antiproliferative therapyin-stent restenosisde novo coronary lesionsNational Institute for Cardiovascular Outcomes ResearchrestenosisPCI with stent deploymentNICORDCBs
…y used in selected cases of de novo coronary lesions to deliver antiproliferative therapy without permanent stenting. While clinical trials and meta-anal…
Drug-Coated Balloon therapyacute coronary syndromesIn-Stent Restenosismultivessel diseaseNational Institute for Cardiovascular Outcomes Researchbifurcation diseasepotent antithromboticsheavily calcified lesionsNICOR
…ibitors in acute coronary syndromes, and the rapid diffusion of Drug-Coated Balloon therapy for In-Stent Restenosis. Abbreviations: DEB – Drug-eluting ball…
Catheter ablationLeeds Teaching Hospitals NHS TrustAtrial fibrillationFibriCheckstrokeHolter monitoring
…cant morbidity, including a five-fold increased risk of stroke. Catheter ablation is an established treatment for symptomatic AF refractory to me…
antiplatelet therapyINOCAstatinmyocardial ischaemiaMedlineGoogle ScholarCochrane LibraryIschaemia with non-obstructive coronary arteries
…ever smoked (P<0.001). Females were less likely to be receiving antiplatelet therapy compared with males (p=0.03; data available in five studies, n=…